Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SCOTT LAURY RAY

Allopathic & Osteopathic Physicians Family Medicine

NPI
1730187782
CMS profile
214946
Location
CLEARWATER, FL

General Payments · PY2018–2024

$1,736.43

  • Reported across 74 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$855.40

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $855.40 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $252.30 7
Novo Nordisk AS $115.88 6
Lilly USA, LLC $92.26 4
Amgen Inc. $61.38 3
Sumitomo Pharma America, Inc. $56.40 3
ABBVIE INC. $51.29 2
PFIZER INC. $50.21 3
GENZYME CORPORATION $35.06 1
EISAI INC. $23.63 1
Astellas Pharma US Inc $23.63 1
Abbott Laboratories $23.08 1
Bayer HealthCare Pharmaceuticals Inc. $22.02 1
SHIELD THERAPEUTICS INC $21.43 1
GlaxoSmithKline, LLC. $13.52 1
Lundbeck LLC $13.31 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $24.26 2
PY2019 $260.91 3
PY2020 $138.52 8
PY2021 $148.00 9
PY2022 $166.37 9
PY2023 $142.97 7
PY2024 $855.40 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $23.08 02/18/2024 Food and Beverage Undisputed 01/23/2026 1125221815 CMS
ABBVIE INC. $18.51 01/10/2024 Food and Beverage Undisputed 01/23/2026 1105390946 CMS
ABBVIE INC. $32.78 10/23/2024 Food and Beverage Undisputed 01/23/2026 1105390949 CMS
Amgen Inc. $22.71 04/24/2024 Food and Beverage Undisputed 01/23/2026 1116047080 CMS
Amgen Inc. $15.52 07/17/2024 Food and Beverage Undisputed 01/23/2026 1116047087 CMS
Amgen Inc. $23.15 12/04/2024 Food and Beverage Undisputed 01/23/2026 1116047093 CMS
Astellas Pharma US Inc $23.63 07/24/2024 Food and Beverage Undisputed 01/23/2026 1139270716 CMS
AstraZeneca Pharmaceuticals LP $20.55 02/07/2024 Food and Beverage Undisputed 01/23/2026 1105286189 CMS
AstraZeneca Pharmaceuticals LP $13.77 03/20/2024 Food and Beverage Undisputed 01/23/2026 1105545713 CMS
AstraZeneca Pharmaceuticals LP $40.24 04/17/2024 Food and Beverage Undisputed 01/23/2026 1104611824 CMS
AstraZeneca Pharmaceuticals LP $18.98 05/23/2024 Food and Beverage Undisputed 01/23/2026 1104530830 CMS
AstraZeneca Pharmaceuticals LP $124.99 06/05/2024 Food and Beverage Undisputed 01/23/2026 1104548094 CMS
AstraZeneca Pharmaceuticals LP $14.40 08/02/2024 Food and Beverage Undisputed 01/23/2026 1105352913 CMS
AstraZeneca Pharmaceuticals LP $19.37 09/09/2024 Food and Beverage Undisputed 01/23/2026 1104360443 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.02 08/12/2024 Food and Beverage Undisputed 01/23/2026 1086203731 CMS
Eisai Inc. $23.63 06/26/2024 Food and Beverage Undisputed 01/23/2026 1110780372 CMS
GENZYME CORPORATION $35.06 11/13/2024 Food and Beverage Undisputed 01/23/2026 1139595022 CMS
GlaxoSmithKline, LLC. $13.52 03/27/2024 Food and Beverage Undisputed 01/23/2026 1116603065 CMS
Lilly USA, LLC $24.66 03/15/2024 Food and Beverage Undisputed 01/23/2026 1135381125 CMS
Lilly USA, LLC $26.08 03/18/2024 Food and Beverage Undisputed 01/23/2026 1135399255 CMS
Lilly USA, LLC $19.26 10/02/2024 Food and Beverage Undisputed 01/23/2026 1135399257 CMS
Lilly USA, LLC $22.26 11/06/2024 Food and Beverage Undisputed 01/23/2026 1135411157 CMS
Lundbeck LLC $13.31 07/08/2024 Food and Beverage Undisputed 01/23/2026 1145959970 CMS
Novo Nordisk Inc $18.94 01/03/2024 Food and Beverage Undisputed 01/23/2026 1096900583 CMS
Novo Nordisk Inc $20.81 03/04/2024 Food and Beverage Undisputed 01/23/2026 1097574342 CMS
Novo Nordisk Inc $21.03 03/14/2024 Food and Beverage Undisputed 01/23/2026 1096707401 CMS
Novo Nordisk Inc $18.19 05/02/2024 Food and Beverage Undisputed 01/23/2026 1097370562 CMS
Novo Nordisk Inc $18.14 07/10/2024 Food and Beverage Undisputed 01/23/2026 1096997402 CMS
Novo Nordisk Inc $18.77 10/25/2024 Food and Beverage Undisputed 01/23/2026 1096583113 CMS
PFIZER INC. $17.60 01/25/2024 Food and Beverage Undisputed 01/23/2026 1131164787 CMS
PFIZER INC. $16.63 03/11/2024 Food and Beverage Undisputed 01/23/2026 1131225822 CMS
PFIZER INC. $15.98 10/16/2024 Food and Beverage Undisputed 01/23/2026 1132121154 CMS
SHIELD THERAPEUTICS INC $21.43 11/20/2024 Food and Beverage Undisputed 01/23/2026 1150155052 CMS
Sumitomo Pharma America, Inc. $15.61 02/14/2024 Food and Beverage Undisputed 01/23/2026 1148908182 CMS
Sumitomo Pharma America, Inc. $21.64 04/03/2024 Food and Beverage Undisputed 01/23/2026 1148908184 CMS
Sumitomo Pharma America, Inc. $19.15 06/06/2024 Food and Beverage Undisputed 01/23/2026 1148908186 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.